A detailed history of Parkside Financial Bank & Trust transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 907 shares of VRTX stock, worth $455,722. This represents 0.06% of its overall portfolio holdings.

Number of Shares
907
Previous 899 0.89%
Holding current value
$455,722
Previous $421,000 -0.0%
% of portfolio
0.06%
Previous 0.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$460.0 - $505.78 $3,680 - $4,046
8 Added 0.89%
907 $421,000
Q2 2024

Aug 05, 2024

BUY
$392.81 - $485.53 $6,284 - $7,768
16 Added 1.81%
899 $421,000
Q1 2024

May 01, 2024

BUY
$407.69 - $446.08 $30,984 - $33,902
76 Added 9.42%
883 $369,000
Q4 2023

Feb 01, 2024

BUY
$343.0 - $410.68 $55,566 - $66,530
162 Added 25.12%
807 $328,000
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $16,909 - $18,123
50 Added 8.4%
645 $224,000
Q2 2023

Aug 15, 2023

BUY
$314.42 - $351.91 $42,132 - $47,155
134 Added 29.07%
595 $209,000
Q1 2023

May 04, 2023

BUY
$283.23 - $323.1 $9,346 - $10,662
33 Added 7.71%
461 $145,000
Q4 2022

Feb 13, 2023

BUY
$285.76 - $321.48 $3,714 - $4,179
13 Added 3.13%
428 $123,000
Q3 2022

Nov 01, 2022

BUY
$273.83 - $305.53 $1,916 - $2,138
7 Added 1.72%
415 $120,000
Q2 2022

Jul 13, 2022

BUY
$234.96 - $292.55 $6,108 - $7,606
26 Added 6.81%
408 $115,000
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $6,642 - $7,829
30 Added 8.52%
382 $99,000
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $4,956 - $6,256
28 Added 8.64%
352 $77,000
Q3 2021

Oct 29, 2021

BUY
$181.39 - $202.99 $1,269 - $1,420
7 Added 2.21%
324 $58,000
Q2 2021

Aug 06, 2021

BUY
$187.49 - $221.1 $3,937 - $4,643
21 Added 7.09%
317 $64,000
Q1 2021

May 10, 2021

SELL
$207.02 - $241.31 $1,863 - $2,171
-9 Reduced 2.95%
296 $63,000
Q4 2020

Feb 09, 2021

SELL
$207.01 - $276.09 $3,933 - $5,245
-19 Reduced 5.86%
305 $72,000
Q3 2020

Nov 06, 2020

SELL
$255.65 - $303.1 $766 - $909
-3 Reduced 0.92%
324 $88,000
Q2 2020

Aug 10, 2020

SELL
$225.48 - $295.8 $11,274 - $14,790
-50 Reduced 13.26%
327 $95,000
Q1 2020

May 05, 2020

BUY
$199.77 - $247.81 $5,194 - $6,443
26 Added 7.41%
377 $90,000
Q4 2019

Jan 30, 2020

BUY
$166.71 - $223.91 $5,501 - $7,389
33 Added 10.38%
351 $77,000
Q3 2019

Nov 05, 2019

BUY
$166.23 - $187.09 $1,496 - $1,683
9 Added 2.91%
318 $54,000
Q2 2019

Aug 06, 2019

BUY
$164.61 - $190.37 $1,810 - $2,094
11 Added 3.69%
309 $57,000
Q1 2019

May 01, 2019

SELL
$163.73 - $194.7 $4,093 - $4,867
-25 Reduced 7.74%
298 $55,000
Q4 2018

Jan 31, 2019

BUY
$151.91 - $192.21 $7,291 - $9,226
48 Added 17.45%
323 $54,000
Q2 2018

Aug 03, 2018

SELL
$145.72 - $169.96 $11,803 - $13,766
-81 Reduced 22.75%
275 $47,000
Q1 2018

May 02, 2018

BUY
$151.6 - $177.13 $1,061 - $1,239
7 Added 2.01%
356 $58,000
Q4 2017

Feb 05, 2018

SELL
$137.28 - $155.55 $1,510 - $1,711
-11 Reduced 3.06%
349 $52,000
Q3 2017

Oct 27, 2017

BUY
$148.13 - $162.24 $53,326 - $58,406
360
360 $55,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.